Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740816 · ClinicalTrials.gov registry record
Comparative Study of Menstrual Blood and Systemic Blood
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 35
- Enrollment target
NCT02740816: Completed study, sponsored by Stanford University.
NCT02740816 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02740816 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics.
Interventions
- OTHER Comparative blood analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02740816
The ClinicalTrials.gov registry entry for NCT02740816 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comparative blood analysis is the first listed.
NCT02740816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02740816 about?
NCT02740816 is a clinical study titled "Comparative Study of Menstrual Blood and Systemic Blood". The purpose is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics.
What is the current status of trial NCT02740816?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2016-03. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02740816?
The interventions under investigation include: Comparative blood analysis (OTHER).
Who is sponsoring clinical trial NCT02740816?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.